Montelukast in Parkinson Disease

NCT06113640 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: levodopa-carbidopa
DRUG: Montelukast

Sponsor

Mostafa Bahaa